+$0.27 (0.93%) Thu · Closed $29.18
+$0.79 (2.69%) ☀ Pre-Market
Oct 30, 9:29 AM ET
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Zacks Investment Research
Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue EstimatesPediatrix Medical Group reported Q3 2026 earnings of $0.72 per share, beating consensus estimates of $0.63 and surpassing revenue expectations. The company has outperformed the S&P 500 by 35.2% year-to-date. However, it received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, with the Medical Services industry ranking in the bottom 40% of sectors.
Zacks Investment Research
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-TermPediatrix Medical Group (MD) is highlighted as a potential growth stock with a #3 (Hold) Zacks Rank and an A VGM Score. The company shows strong growth prospects with forecasted year-over-year earnings growth of 13.7% for fiscal 2026, a B Growth Style Score, and a positive average earnings surprise of +17.4%. Two analysts revised earnings estimates higher in the last 60 days, with the consensus estimate increasing to $2.32 per share.
Headlines open the publisher's site.
